Dental Implants in Patients with <scp>S</scp>jögren's Syndrome

Korfage, Anke; Raghoebar, Gerry M.; Arends, Suzanne; Meiners, Petra M.; Visser, Anita; Kroese, Frans G. M.; Bootsma, Hendrika

doi:10.1111/cid.12376

Cited by 33 publications

(75 citation statements)

References 33 publications

(75 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Isidor et al [34] reported of 84 % success rate after 4-year follow-up of 54 implants in 8 patients, while Payne et al [35] achieved 88.4 % success rate of 26 implants placed in three patients but with only 2-year follow-up. A more recent publication examining 50 patients with SS found a prevalence of peri-implantitis of 14 % of the patients (11 % of the implants), which is similar to what is reported for systemically healthy individuals [36]. With a median follow-up of 46 months, the implant survival was 97 %; of the 142 implants inserted, four implants in two patients were lost.…”

Section: Dental Implantssupporting

confidence: 68%

Epidemiology of Sjögren’s Syndrome—from an Oral Perspective

Bolstad

Skarstein

2016

Curr Oral Health Rep

View full text Add to dashboard Cite

Oral symptoms are among the most distressing manifestations for patients with Sjögren’s syndrome (SS). The feeling of dry mouth is unpleasant, and hyposalivation may contribute to difficulty in speaking, chewing and swallowing and reduced quality of life. Reduced salivary flow increases the risk for dental caries and problems with prosthetic replacement. It seems that SS is not as frequently occurring as previously anticipated. Population-based prevalence studies on primary SS in Europe, conducted on large background populations and in accordance with the AECG criteria, reported of a prevalence of 1–9 cases per 10,000 people. This gives a combined prevalence of nearly 39/100,000 (~0.04 %). The cause of Sjögren’s syndrome is even now not fully understood, and the treatment of oral symptoms is still mostly palliative. Hopefully, useful information will appear from the new methods that are now available for genome wide association studies, epigenetics, DNA methylation studies, and proteomics. Similarly, this is anticipated for the immunological side of the story. The interferon signature, the interferon γ/interferon α mRNA ratio, and CXCL13 are among the proposed biomarkers of active disease. In this review, we provide an update on oral aspects of Sjögren’s syndrome with emphasis on the latest publications on these topics.

show abstract

Section: Dental Implantssupporting

confidence: 68%

Epidemiology of Sjögren’s Syndrome—from an Oral Perspective

Bolstad

Skarstein

2016

Curr Oral Health Rep

View full text Add to dashboard Cite

show abstract

“…In total 16 prospective studies [14,18,19,28,35-40,44,45,47,48,50,53] from which 5 were controlled clinical trials [38-40,44,48] and 1 cross-sectional study [45], 23 retrospective studies [15-17,20,23-27,29-34,41-43,46,49,51,52,54] and two case series studies [21,22] were included in present research.…”

Section: Resultsmentioning

confidence: 99%

“…In two studies the effect of HIV was analysed [39,40]. One by one articles were included in evaluating the effect of following diseases and stages: Crohn‘s disease [47], Sjögren’s syndrome [49], ectodermal dysplasia [50] and immunosuppression after transplantation [48]. …”

Section: Resultsmentioning

confidence: 99%

“…One retrospective study was identified that shows success of implantation in 50 patient‘s group with Sjögren’s syndrome [49]. Early complications rate was 3% of 140 implants.…”

Section: Resultsmentioning

confidence: 99%

“…Early complications rate was 3% of 140 implants. Although patients showed more signs of peri-implant mucositis, Korfage et al [49] stated this clinically irrelevant, and after median follow-up of 3.8 years prevalence of peri-implantitis was 11% which is comparable with healthy patients. There is some caution with regard to the potentially increased risk on peri-implantitis in the long term [49].…”

Section: Resultsmentioning

confidence: 99%

See 2 more Smart Citations

General Diseases Influence on Peri-Implantitis Development: a Systematic Review

Guobis¹,

Pacauskienė²,

Astramskaitė

2016

JOMR

View full text Add to dashboard Cite

ObjectivesTo systematically review the influence of systemic diseases or medications used in their treatment on the dental implant therapy success.Material and MethodsThe search strategy was implemented on the National Library of Medicine database (MEDLINE) (Ovid) and EMBASE electronic databases between January 2006 and January 2016. Human studies with available English articles analysing the relationship between dental implant therapy success and systemic diseases, such as diabetes mellitus, AIDS/HIV, rheumatoid arthritis, osteoporosis, Crohn’s disease, cardiovascular diseases, scleroderma, Sjögren’s syndrome, lichen planus, ectodermal dysplasia, post-transplantation status, were included in present review according to the PRISMA guidelines. The review protocol was registered on PROSPERO system with the code CRD42016033662.ResultsPresent review included forty one retrospective and prospective follow-up studies, case-control studies, case report series and cohort studies. Despite some limitations this study reveals positive results of implantation in most systemic conditions that should be interpreted with caution. Influence of cardiovascular diseases on the dental implantation success should be explored deeply, because of controversial results and likelihood of comorbidity expressed by a history of cardiovascular diseases and periodontitis. There is only a weak relationship with bone density in osteoporosis and implant failure. All the other diseases did not show significant effect on implantation success.ConclusionsRecent studies with low strength of evidence and controversy show that systemic diseases may have potential effect on the success of implantation, but further detailed studies are needed to provide these findings.

show abstract

Dental Implants in Patients with Sjögren's Syndrome

2018

Evidence‐based Implant Dentistry and Systemic Conditions

View full text Add to dashboard Cite

Dental Implants in Patients with Sjögren's Syndrome

Abstract: Implant therapy is common in our cohort of SS patients. In spite of shortcomings of our retrospective analysis, implants in SS patients seem to perform comparable with implants in healthy patients.

Cited by 33 publications

References 33 publications

Epidemiology of Sjögren’s Syndrome—from an Oral Perspective

Epidemiology of Sjögren’s Syndrome—from an Oral Perspective

General Diseases Influence on Peri-Implantitis Development: a Systematic Review

Dental Implants in Patients with Sjögren's Syndrome

Contact Info

Product

Resources

About